Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Timothy Springer
Boston Children's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Morphic Rock Therapeutic, Inc.
Other : Founder, equity ((b)(4)), and consulting income
In 2014, Dr. Springer helped found a company, Morphic Rock Therapeutic, Inc. (“Company”), which was formed to develop small molecule antagonists of integrins based on newly defined chemotypes that block the integrin and binding site and have additional desired properties. The company will design new molecules, have them synthesized, and test their mode of antagonism, pharmacology, and in vivo therapeutic effects. Dr. Springer’s research in the subject grant involves determining integrin crystal structures.
Although Dr. Springer’s research is distinct from the Company’s work in that his research focuses on understanding how small molecules bind to integrins and alter their conformation, it does have the potential to indirectly benefit Company aims to design, synthesize, and optimize new molecules.
Leukocyte Adhesion Receptors Mac-1 and P150,95
Leukocyte integrins are important in defense against infection. This grant deepens our understanding of their structure and function, and is enabling for treatment of disease and improvement of therapeutics for autoimmune and inflammatory diseases.
Filed on November 24, 2015.
Tell us what you know about Timothy Springer's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Timothy Springer filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Timothy Springer | Boston Children's Hospital | Conflict of Interest | Morphic Therapeutics, Inc. | >$600,000 |
| Timothy Springer | Boston Children's Hospital | Conflict of Interest | Morphic Therapeutics, Inc. | $80,000 - $99,999 |
| Timothy Springer | Boston Children's Hospital | Conflict of Interest | Morphic Therapeutic, Inc. | $80,000 - $99,999 |
| Timothy Spring | Boston Children's Hospital | Conflict of Interest | Morphic Rock Therapeutic, Inc. | $0 - $4,999 |
| Tim Springer | Boston Children's Hospital | Conflict of Interest | Morphic Rock Therapeutics, Inc. | $0 - $4,999 |
| Timothy Springer | Boston Children's Hospital | Conflict of Interest | Morphic Therapeutic, Inc. | Value cannot be readily determined |
| Tim Springer | Boston Children's Hospital | Conflict of Interest | Morphic Rock Therapeutics, Inc. | Value cannot be readily determined |
| Tim Springer | Boston Children's Hospital | Conflict of Interest | Morphic Rock Therapeutics, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.